Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automating region selection with genetic algorithms for energy landscape analyses of brain dynamics.

Patterns (New York, N.Y.)·2026
Same author

Task-guided generative adversarial networks for synthesizing and augmenting structural connectivity matrices for connectivity-based prediction.

Network neuroscience (Cambridge, Mass.)·2025
Same author

Hemispheric Lateralization in Older Adults Who Habitually Play Darts: A Cross-Sectional Study Using Functional Near-Infrared Spectroscopy.

Healthcare (Basel, Switzerland)·2024
Same author

Interpersonal brain synchronization during face-to-face economic exchange between acquainted dyads.

Oxford open neuroscience·2024
Same author

Predicting the Degree of Distracted Driving Based on fNIRS Functional Connectivity: A Pilot Study.

Frontiers in neuroergonomics·2024
Same author

Demarcation Line Determination for Diagnosis of Gastric Cancer Disease Range Using Unsupervised Machine Learning in Magnifying Narrow-Band Imaging.

Diagnostics (Basel, Switzerland)·2022

Related Experiment Video

Updated: May 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Training data selection method for prediction of anticancer drug effects using a genetic algorithm with local search.

Tomoyuki Hiroyasu1, Yota Miyabe, Hisatake Yokouchi

  • 1Department of Life and Medical Sciences, Doshisha University, Japan. tomo@mis.doshisha.ac.jp

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
|January 19, 2012
PubMed
Summary

This study introduces a novel method for selecting training data to predict anticancer drug effects. It utilizes a Support Vector Machine (SVM) combined with a genetic algorithm (GA) for improved accuracy.

Related Experiment Videos

Last Updated: May 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Area of Science:

  • Computational biology
  • Machine learning
  • Pharmacology

Background:

  • Support Vector Machines (SVM) are typically used for broad data classification.
  • Selecting optimal training data is crucial for accurate predictive models in drug discovery.

Purpose of the Study:

  • To develop an advanced training data selection method for predicting anticancer drug efficacy.
  • To adapt SVM for nuanced data discrimination in the context of drug response prediction.

Main Methods:

  • The proposed method employs a Support Vector Machine (SVM) for specialized data subset identification.
  • A genetic algorithm (GA) with local search is integrated to treat training data selection as an optimization problem.
  • The composition of the GA was specifically examined for this application.

Main Results:

  • The method was validated using an artificial anticancer drug dataset.
  • The approach successfully created a verifiable and predictable discriminant function through optimized training data selection.
  • Demonstrated effectiveness in identifying relevant data for drug effect prediction.

Conclusions:

  • The proposed SVM and GA-based training data selection method enhances the predictability of anticancer drug effects.
  • This approach offers a robust strategy for building accurate predictive models in pharmaceutical research.
  • The findings suggest a significant advancement in machine learning applications for drug discovery and development.